Brunswick company making scientific advances toward more effective prescriptions at lower costs

BRUNSWICK, Maine — The side effects of any new pharmaceutical drug can often be scarier than what they’re meant to treat; but how can drug companies do better testing?

They can start with a company called InSphero. Armand Wolf, the Chief Scientific Officer for the company, spent years working in drug development in the pharmaceutical field.

“Most of the drugs, when they’re just reaching clinical phase, 90% of them are failing,” says Wolf. Those drugs are failing – on average – 10 years into testing. “It will cost about $1-2 Billion, so this is a huge waste of money.” Read more

Related Posts

Maine’s life sciences sector growth could outpace other industries

Maine’s $2.3 billion life sciences sector, which employed close to 10,000 people in 2024, will outpace the growth of many other...

13 January 2025

IDEXX gets wiggle room to buy back more shares

IDEXX Laboratories Inc. (Nasdaq: IDXX), a Westbrook-based maker of veterinary diagnostics and software, has the green light from its board of...

10 December 2024

Maine’s first accredited lab for PFAS testing is expanding to meet demand

NORRIDGEWOCK, Maine — This week, the Biden administration moved to prevent dangerous “forever chemicals” from being released onto the market after a less...

6 December 2024